Coloplast A/S Class B · MUN:CBH

Coloplast A/S Class B financial statements

Coloplast A/S Class B's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in DKK

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue28.9B27.9B27.0B24.5B22.6B19.4B18.5B17.9B16.4B15.5B
Cost of revenue9.70B8.93B8.76B8.17B7.05B6.11B5.93B5.79B5.38B4.96B
Gross profit19.2B18.9B18.3B16.3B15.5B13.3B12.6B12.2B11.1B10.6B
Research and development1.07B946.0M913.0M872.0M866.0M755.0M708.0M692.0M640.0M574.0M
Selling, general and administrative10.8B1.24B1.11B1.00B762.0M762.0M757.0M653.0M623.0M
Operating income7.36B7.20B7.32B6.77B6.44B6.36B5.85B5.16B5.09B5.02B
Depreciation and amortization4.43B863.0M839.0M1.07B930.0M792.0M851.0M651.0M625.0M611.0M
EBITDA11.8B8.06B8.16B7.84B7.37B7.15B6.71B5.81B5.72B5.63B
Interest expense747.0M1.15B1.10B719.0M240.0M57.0M63.0M54.0M44.0M45.0M
Income before tax3.85B6.16B6.39B6.03B6.13B6.23B5.47B5.03B5.01B4.95B
Income tax775.0M2.52B1.34B1.24B1.42B1.41B1.27B1.16B1.16B1.15B
Net income3.07B3.64B5.05B4.78B4.71B4.83B4.20B3.87B3.85B3.80B
Earnings per share, basic13.6416.1322.4622.1922.1122.6319.6818.1718.1017.87
Earnings per share, diluted16.1322.46

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents511.0M947.0M788.0M911.0M414.0M448.0M323.0M356.0M297.0M314.0M
Short-term investments-39.0M219.0M226.0M262.0M313.0M310.0M315.0M
Receivables5.00B4.66B4.67B4.59B4.32B3.44B3.27B3.35B3.07B3.15B
Inventory4.06B3.92B3.67B3.52B3.19B2.43B2.23B1.93B1.73B1.69B
Current assets9.95B10.5B10.4B9.94B8.77B6.99B6.49B6.36B5.59B6.19B
Property, plant and equipment6.20B5.65B4.13B3.58B3.16B2.84B2.90B2.69B
Goodwill16.5B19.3B19.4B20.0B11.8B2.03B1.98B2.03B1.98B1.72B
Total assets46.3B48.4B48.1B48.2B35.0B15.8B13.5B12.7B11.8B12.1B
Accounts payable1.70B1.32B1.52B1.29B1.24B1.04B814.0M859.0M751.0M675.0M
Current liabilities13.5B6.50B10.2B16.3B7.34B6.31B4.98B4.94B4.71B5.42B
Long-term debt13.6B19.4B16.6B11.6B16.4B0
Total debt21.5B22.6B22.6B19.6B18.7B2.79B1.75B1.21B1.36B1.46B
Total liabilities32.0B32.2B30.1B30.9B26.7B7.67B6.09B5.82B5.35B6.10B
Shareholders' equity14.3B16.1B17.9B17.3B8.29B8.17B7.41B6.91B6.42B5.95B
Shares outstanding225.4M225.4M224.9M215.5M212.8M213.2M213.3M213.1M212.4M212.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations8.01B6.64B2.77B4.23B5.10B5.29B4.76B4.36B4.36B3.25B
Capital spending-1.39B-1.31B-1.17B-1.24B-1.14B-1.97B-931.0M-636.0M-669.0M-685.0M
Free cash flow6.62B5.34B1.60B2.98B3.96B3.32B3.83B3.72B3.69B2.57B
Cash from investing-1.73B-1.25B-1.34B-8.96B-11.8B-2.01B-901.0M-591.0M-947.0M-1.62B
Cash from financing-6.75B-5.19B-1.52B5.26B6.59B-3.18B-3.86B-3.71B-3.43B-1.86B
Dividends paid-5.18B-4.96B-4.72B-4.25B-4.04B-3.83B-3.61B-3.40B-3.29B-2.86B
Share buybacks0-619.0M-500.0M-500.0M-500.0M-500.0M-500.0M
Change in cash-436.0M207.0M-88.0M534.0M-34.0M125.0M-33.0M59.0M-17.0M-241.0M